Kane Biotech Inc (TSXV:KNE)
C$ 0.13 0 (0%) Market Cap: 17.23 Mil Enterprise Value: 18.60 Mil PE Ratio: 4.33 PB Ratio: 0 GF Score: 37/100

Q1 2023 Kane Biotech Inc Earnings Call Transcript

May 25, 2023 / 08:30PM GMT
Release Date Price: C$0.11
Operator

Good afternoon, and thank you for standing by. Welcome to Kane Biotech's first-quarter 2023 earnings conference call. (Operator Instructions) This conference is being recorded today, May 25, 2023. I would now like to turn the conference call over to Nicole, Kane Biotech's Investor Relations Advisor. Please go ahead.

Nicole Sendey
Kane Biotech Inc. - IR & Public Relations

Thank you, operator. Good afternoon and welcome, everyone to Kane Biotech's quarterly earnings conference call. We are delighted to have you join us today This call will cover Kane's financial and operating results for the first quarter of 2023, along with a discussion of some of our recent highlights and goal for 2023 and beyond.

Following our prepared remarks, we will open the conference call to a question-and-answer period. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards. Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call contain certain forward-looking information and statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot